-62%
Ourlyard™ Medical VeinEase Therapy Spray
Farashin asali shine: $49.90.$18.91Farashin yanzu: $18.91.
Ourlyard™ Medical VeinEase Therapy Spray
Yana taimakawa inganta wurare dabam dabam da ƙarfafa lafiyar capillary don rage atherosclerosis da rage bayyanar Spider da varicose veins.
Amfani da asibiti na Ourlyard ™ Medical VeinEase Therapy Spray ya gano cewa mutanen da ke amfani da feshin a yankin da abin ya shafa sun sami damar warkar da varicose veins da kashi 60% a cikin makonni 4 na farko da fiye da 95% tare da ci gaba da amfani har zuwa makonni 12. varicose veins.
HANYAR AMFANI
- 1. Shirya samfurin.
- 2. Fesa a ko'ina a kan kafafun ka sau biyu zuwa uku
- 3. Massage na minti 2-3 har sai an shafe shi gaba daya.
- 4. Kyakkyawan sakamako na dindindin amfani don akalla makonni 6.
Ourlyard™ Medical VeinEase Therapy Spray yana da masu zuwa fasali samfurin:
- Suna: Ourlyard ™ Medical VeinEase Therapy Spray
- Abubuwan Nidodi: 30ml
- Kunshin ya haɗa da: 1 x Ourlyard™ Medical VeinEase Therapy Spray
Ourlyard™ Medical VeinEase Therapy Spray
Yana taimakawa inganta wurare dabam dabam da ƙarfafa lafiyar capillary don rage atherosclerosis da rage bayyanar Spider da varicose veins.
Amfani da asibiti na Ourlyard ™ Medical VeinEase Therapy Spray ya gano cewa mutanen da ke amfani da feshin a yankin da abin ya shafa sun sami damar warkar da varicose veins da kashi 60% a cikin makonni 4 na farko da fiye da 95% tare da ci gaba da amfani har zuwa makonni 12. varicose veins.
HANYAR AMFANI
- 1. Shirya samfurin.
- 2. Fesa a ko'ina a kan kafafun ka sau biyu zuwa uku
- 3. Massage na minti 2-3 har sai an shafe shi gaba daya.
- 4. Kyakkyawan sakamako na dindindin amfani don akalla makonni 6.
Ourlyard™ Medical VeinEase Therapy Spray yana da masu zuwa fasali samfurin:
- Suna: Ourlyard ™ Medical VeinEase Therapy Spray
- Abubuwan Nidodi: 30ml
- Kunshin ya haɗa da: 1 x Ourlyard™ Medical VeinEase Therapy Spray
Kasance farkon wanda zai bita "Ourlyard™ Medical VeinEase Therapy Spray"
Dole ne ka zama shigad da a don gabatar da bita.
Sharhi
Babu reviews yet.